Rain Therapeutics Inc (RAIN) Event Aug. 13, 2022, 06:21 UTC 114 0 comments Rain Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress Comment Full text
Rain Therapeutics Inc (RAIN) Event Aug. 13, 2022, 06:19 UTC 115 0 comments UPDATE -- Rain Therapeutics Announces Completion of Enrollment in Phase 3 MANTRA Trial for Milademetan in Liposarcoma Comment Full text
ArgenX Inc (ARGX) Event Aug. 12, 2022, 12:19 UTC 28 1 comments (80% Positive) ArgenX Inc (ARGX) Announces Clinical Development Update (Form 6-K) Comment Full text
Rapid Micro Biosystems Inc (RPID) Event Aug. 12, 2022, 11:30 UTC 32 1 comments (30% Negative) RAPID MICRO BIOSYSTEMS, INC. (RPID) Reports Q3 2022 Financial Results Comment Full text
Leap Therapeutics Inc (LPTX) Event Aug. 12, 2022, 11:11 UTC 38 1 comments (10% Negative) Leap Therapeutics, Inc. (LPTX) Reports Q3 2022 Financial Results Comment Full text
Applied Therapeutics (APLT) Event Aug. 12, 2022, 11:06 UTC 37 1 comments (30% Negative) APPLIED THERAPEUTICS, INC. (APLT) Reports Q3 2022 Financial Results Comment Full text
Zai Lab Limited (ZLAB) Event Aug. 12, 2022, 02:18 UTC 113 0 comments Partner News: argenx Announces European Commission Approval ofVYVGART™ (efgartigimod alfa-fcab) for the Treatment of Generalized Myasthenia Gravis News August 11, 2022 Comment Full text
Instil Bio Inc (TIL) Event Aug. 12, 2022, 00:00 UTC 32 1 comments (75% Positive) Instil Bio, Inc. (TIL) Reports 48% Loss Reduction for 2022-06-30 Comment Full text
Applied Therapeutics (APLT) Event Aug. 12, 2022, 00:00 UTC 32 1 comments (41% Neutral) Applied Therapeutics, Inc. (APLT) Reports Net Loss for 2022-06-30 Comment Full text
Geron Corporation Inc (GERN) Event Aug. 11, 2022, 13:07 UTC 115 0 comments Geron - August 2022 Corporate Presentation Comment Full text